Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma.

Mariana Bastos-OreiroJavier OrtizVirginia PradilloEduardo SalasCarolina Marínez-LapercheAndrés MuñozIsmael BuñoJosé Luis Diéz-MartinJose Manuel SoriaCristina Pascual Izquierdo

Published in: Cancer medicine (2021)

These results show that by incorporating genetic and clinical data into VTE risk assessment, the TiC-LYMPHO score can categorize patients with lymphoma better in terms of their risk of VTE and allow individualized thromboprophylaxis to be prescribed.

Keyphrases

venous thromboembolism
risk assessment
diffuse large b cell lymphoma
electronic health record
genome wide
direct oral anticoagulants
copy number
heavy metals
obsessive compulsive disorder
dna methylation